Crystal Structures of ALK and LTK Receptor Tyrosine Kinases and Their Ligands
AssigneesVib Vzw, Universiteit Gent
InventorsSavvas Savvides, Steven De Munck
Life of this patent
Estimating the term…
Abstract
The present invention provides co-crystals of the anaplastic lymphoma kinase (ALK) and its ligand ALKAL2 and the related leukocyte tyrosine kinase (LTK) and its ligand ALKAL1. The invention also provides computer-assisted and other methods for selecting molecules able to modulate the interaction between ALK, LTK and their respective ligands.
Claims6
A composition comprising a crystalline form selected from i) ALKTG (SEQ ID NO:
- 1) interacting with ALKAL2 (SEQ ID NO:
- 2) and ii) LTKTG (SEQ ID NO:
- 3) interacting with ALKAL1 (SEQ ID NO:
- 4) and Nb3.16 (SEQ ID NO:
- 5), characterized in that the crystals are:
- i) a crystal between ALKTG (SEQ ID NO:
- 1) interacting with ALKAL2 (SEQ ID NO:
- 2) in the space group P43212, with the following crystal lattice constants:
- a=97.57 ű5%, b=97.57 ű5%, c=355.35 ű5%, α=β=γ=90°, and
- ii) a crystal between LTKTG (SEQ ID NO:
- 3) interacting with ALKAL1 (SEQ ID NO:
- 4) and Nb3.16 (SEQ ID NO:
- 5) in the space group P61, with the following crystal lattice constants:
- a=129.11 ű5%, b=129.11 ű5%, c=109.75 ű5%, α=90°, β=90°, γ=120°.
(canceled)
A method of identifying, designing or screening for a compound that can interact with the complex i) ALKTG-ALKAL2 or to the complex ii) LTKTG-ALKAL1-Nb3.16, the method comprising:
- performing structure-based identification, design, or screening of a test compound based on the test compound's interactions with the complex i) ALKTG-ALKAL2 or to the complex ii) LTKTG-ALKAL1-Nb3.16.
A method for identifying an agonist or antagonist compound for the interaction between the members of the complex i) ALKTG-ALKAL2 or the complex ii) LTKTG-ALKAL1-Nb3.16L, the compound comprising an entity selected from the group consisting of an antibody, a peptide, a non-peptide molecule and a chemical compound, wherein the compound enhances or disrupts the interaction of the members of the complex i) ALKTG-ALKAL2 or the complex ii) LTKTG-ALKAL1-Nb3.16, the method comprising:
- i) introducing into suitable computer program parameters defining an interacting surface based on the conformation of the complex i) ALKTG-ALKAL2 or the complex ii) LTKTG-ALKAL1-Nb3.16 corresponding to the atomic coordinates 7NWZ or 7NX0 present in the on line RCSB protein database on Mar. 17, 2021, wherein said program displays a three-dimensional model of the interacting surface,
- ii) creating a three-dimensional structure of a test compound in the computer program;
- and
- displaying a superimposing model of the test compound on the three-dimensional model of the interacting surface.
Dependencies are inferred from the claim text.